Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1593447

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1593447

Radiofrequency Ablation Devices Market Size, Share, Growth Analysis, By Type, By Component Type, By Application, By Region - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Radiofrequency Ablation Devices Market size was valued at USD 4.34 Billion in 2022 and is poised to grow from USD 4.85 Billion in 2023 to USD 11.66 Billion by 2031, growing at a CAGR of 11.6% in the forecast period (2024-2031).

The radiofrequency ablation devices market is experiencing robust growth driven by the rising prevalence of chronic conditions, an increasing preference for minimally invasive surgical options, and significant technological advancements. As healthcare systems prioritize outpatient procedures and address the growing cancer burden, the demand for these medical devices is accelerating. However, challenges such as the high costs associated with radiofrequency ablation devices pose barriers to adoption, particularly in middle-income and developing nations. Additionally, a shortage of skilled professionals in these regions further hampers market expansion. Despite these obstacles, the market presents substantial opportunities, particularly in rapidly developing areas and through ongoing innovations in RFA technologies. Developments such as the integration of imaging systems and improvements in electrode design are set to enhance procedural efficacy and safety, positioning the market for continued growth. Overall, while challenges exist, the future of the radiofrequency ablation devices market appears promising, supported by rising healthcare needs and technological progress.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Radiofrequency Ablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Radiofrequency Ablation Devices Market Segmental Analysis

Global Radiofrequency Ablation Devices Market is segmented by Type, Component Type, Application, End Use, and region. Based on Type, the market is segmented into Unipolar Radiofrequency Ablation, and Bipolar Radiofrequency Ablation. Based on Component Type, the market is segmented into Disposable equipment, Capital equipment, and Reusable equipment. Based on Application, the market is segmented into Surgical oncology, Cardiology & cardiac rhythm management, Cosmetology, Gynecology, and Pain management. Based on Application, the market is segmented into Hospital, Ambulatory Surgery Centers, and Research laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Radiofrequency Ablation Devices Market

The global radiofrequency ablation (RFA) devices market is being driven by the rising demand for minimally invasive procedures, which provide numerous advantages over traditional surgical methods, such as reduced infection risks, shorter recovery periods, and decreased postoperative discomfort. Additionally, the expanding aging population, which is more susceptible to chronic diseases and tumors requiring RFA treatment, is further propelling market growth. As healthcare systems increasingly prioritize patient-centric and cost-effective treatment options, the inclination towards RFA procedures continues to surge, effectively positioning the market for significant expansion in response to evolving medical needs and demographic trends.

Restraints in the Global Radiofrequency Ablation Devices Market

The global radiofrequency ablation (RFA) devices market faces significant restraints due to concerns over potential complications associated with the procedure, including bleeding, damage to adjacent tissues, and infections. These risks can lead to hesitation among both healthcare providers and patients, discouraging the adoption of RFA as a preferred treatment option. Moreover, the market is further constrained by a shortage of skilled professionals in certain regions, which limits the effective utilization of RFA technologies. This dual challenge of perceived risks and insufficient expertise could hinder market growth and slow the acceptance of radiofrequency ablation as a mainstream therapeutic modality.

Market Trends of the Global Radiofrequency Ablation Devices Market

The Global Radiofrequency Ablation Devices market is currently witnessing a significant trend towards the adoption of advanced technologies such as Pulsed Field Ablation (PFA). This innovative approach leverages large electrodes to reduce current density, enabling non-thermal ablation that primarily targets myocardial tissue with minimal impact on surrounding structures like nerves and the esophagus. Recent studies highlighting PFA's efficacy have spurred interest from healthcare professionals and researchers alike, suggesting a shift in treatment paradigms for conditions like cardiac arrhythmias. As a result, the demand for radiofrequency ablation devices incorporating PFA technology is expected to grow, driving market expansion and innovation.

Product Code: SQMIG35A2903

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Value Chain Analysis
  • Technology Analysis
  • Patent Analysis
  • Pricing Analysis
  • Case Study Analysis
  • Regulatory Analysis
  • PESTEL Analysis
  • Customer Buying Criteria Analysis

Radiofrequency Ablation Devices Market, By Type

  • Market Overview
  • Unipolar Radiofrequency Ablation
  • Bipolar Radiofrequency Ablation

Radiofrequency Ablation Devices Market, By Component Type

  • Market Overview
  • Disposable equipment
  • Capital equipment
  • Reusable equipment

Radiofrequency Ablation Devices Market, By Application

  • Market Overview
  • Surgical oncology
  • Cardiology & cardiac rhythm management
  • Cosmetology
  • Gynecology
  • Pain management

Radiofrequency Ablation Devices Market, By End Use

  • Market Overview
  • Hospital
  • Ambulatory Surgery Centers
  • Research Laboratories

Radiofrequency Ablation Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CryoLife, Inc. (Artivion, Inc.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AtriCure, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ELIAS Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eppendorf AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sientra, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neotract, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ablative Solutions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!